Binder Section 4

Neonatal Sepsis, Neuroimmune Intelligence Monitoring, Self-Tolerance Preservation & Septic Shock Prevention

Program Code: SCF-DBI-NICU-SEPSIS-0001

Operational Window: Birth → NICU Discharge

Primary Objective: Rapid identification, containment, treatment, and recovery from neonatal infection while preserving neurodevelopmental integrity, endothelial intelligence, microbiome stability, and immunologic self-tolerance.

SECTION 4.1

CLINICAL POSITIONING

Traditional Sepsis Management

Traditional NICU sepsis care focuses on:

• Pathogen identification
• Antibiotic administration
• Hemodynamic stabilization
• Organ support

SCF-DBI Expansion

SCF-DBI recognizes neonatal sepsis as a biological intelligence disruption syndrome involving:

Neuroimmune dysregulation

Endothelial dysfunction

Microbiome destabilization

Developmental interruption

Metabolic adaptation failure

Self-tolerance loss

Core Principle

The objective is not only pathogen elimination.

The objective is preservation of developmental biological intelligence while eliminating infection.

SECTION 4.2

NEONATAL SEPSIS CLASSIFICATION

Class I

Suspected Sepsis

Characteristics:

• Maternal risk factors
• Mild laboratory abnormalities
• Stable physiology

Class II

Confirmed Sepsis

Characteristics:

• Positive cultures
• Clinical symptoms
• Inflammatory activation

Class III

Severe Sepsis

Characteristics:

• Organ dysfunction
• Endothelial activation
• ANMS decline

Class IV

Septic Shock

Characteristics:

• Perfusion failure
• Persistent lactate elevation
• Hemodynamic instability

Class V

Refractory Septic Shock

Characteristics:

• Progressive multi-system destabilization
• Severe ANMS collapse
• ECMO consideration

SECTION 4.3

EARLY-ONSET SEPSIS WORKFLOW (EOS)

Definition

Infection occurring:

Birth → 72 Hours

Risk Factors

Maternal Chorioamnionitis

Maternal Fever

Prolonged Rupture of Membranes

Group B Streptococcus

Maternal Sepsis

EOS SCREENING BUNDLE

Clinical Assessment

Evaluate:

Respiratory distress

Temperature instability

Hypotonia

Feeding intolerance

Apnea

Perfusion abnormalities

Laboratory Assessment

CBC

Blood culture

CRP

Procalcitonin

Lactate

Blood gas

SCF Neuroimmune Assessment

Evaluate:

Neuroimmune Stability Score

Early ANMS

Self-Tolerance Recovery Index Baseline

SECTION 4.4

LATE-ONSET SEPSIS WORKFLOW (LOS)

Definition

Infection occurring:

72 Hours of Life

Major Sources

Central lines

Ventilation

Surgical procedures

Gastrointestinal translocation

NICU environmental exposure

LOS Surveillance Protocol

Monitor Daily:

Temperature

Perfusion

Feeding tolerance

Weight progression

Respiratory support requirements

ANMS trajectory

SECTION 4.5

SCF-DBI NEUROIMMUNE INTELLIGENCE MONITORING

Purpose

Detect immune dysregulation before overt septic deterioration.

Neuroimmune Surveillance Variables

Conventional

CBC

CRP

Procalcitonin

Blood cultures

Expanded SCF Variables

IL-6

IL-1β

TNF-α

IL-10

HLA-DR expression

Treg activity

Neuroimmune Risk Categories

Green

Stable immune adaptation

Yellow

Early activation

Orange

Escalating dysregulation

Red

High cytokine storm risk

SECTION 4.6

RHENOVA IMMUNOLOGIC SELF-TOLERANCE PRESERVATION PROGRAM

Strategic Position

One of the major drivers of neonatal deterioration is uncontrolled inflammatory amplification.

Objective

Preserve:

Immune regulation

Immune tolerance

Developmental adaptation

Tissue repair capacity

Self-Tolerance Domains

Domain 1

Inflammatory Balance

Domain 2

Immune Regulation

Domain 3

Endothelial Stability

Domain 4

Regenerative Capacity

Domain 5

Developmental Integrity

Self-Tolerance Recovery Index (STRI)

Classification:

Green

80

Yellow

60–79

Orange

40–59

Red

<40

SECTION 4.7

GLYCOCALYX PROTECTION BUNDLE DEPLOYMENT DURING SEPSIS

Purpose

Prevent endothelial collapse.

Core Threats

Capillary leak

Microvascular dysfunction

Pulmonary injury

NEC progression

Multi-organ dysfunction

Bundle Components

Perfusion Optimization

Maintain:

Age-appropriate perfusion targets

Oxygen Stewardship

Avoid:

Hyperoxia

Hypoxia

Fluid Stewardship

Avoid:

Over-resuscitation

Under-resuscitation

Inflammatory Surveillance

Monitor:

Lactate

Perfusion

Endothelial biomarkers

SECTION 4.8

MICROBIOME STABILIZATION DURING SEPSIS

Objectives

Reduce:

Dysbiosis

NEC risk

Fungal overgrowth

Antibiotic-associated injury

Core Interventions

Human Milk Prioritization

Antibiotic Stewardship

Feeding Optimization

Gut Barrier Surveillance

SECTION 4.9

SEPTIC SHOCK PREVENTION PROGRAM

Strategic Position

The greatest opportunity is preventing progression from infection to shock.

Early Warning Indicators

Physiologic

Increasing oxygen requirement

Feeding intolerance

Perfusion deterioration

Temperature instability

Laboratory

Rising lactate

Rising CRP

Rising IL-6

Rising procalcitonin

ANMS

Falling Neuroimmune Score

Falling Neurovascular Score

Falling Metabolic Score

SECTION 4.10

ANMS SEPTIC ESCALATION PATHWAY

Level 0

Green

ANMS >80

Standard monitoring

Level 1

Yellow

ANMS 60–79

Increase surveillance frequency

Level 2

Orange

ANMS 40–59

Activate Sepsis Prevention Bundle

Initiate multidisciplinary review

Level 3

Red

ANMS <40

Activate Septic Shock Prevention Protocol

Immediate physician escalation

SECTION 4.11

CURATIVE SEPSIS MANAGEMENT SOP

SCF-PCR CURATIVE PHASE

Goal

Rapid pathogen control while minimizing collateral developmental injury.

Core Components

Culture Acquisition

Before antibiotics when feasible.

Antimicrobial Therapy

Per institutional guidelines.

Hemodynamic Stabilization

Perfusion-focused management.

Respiratory Support

As clinically indicated.

Surgical Source Control

If applicable.

SECTION 4.12

RESTORATIVE SEPSIS RECOVERY PROGRAM

Objective

Transition from pathogen control to developmental recovery.

Recovery Targets

Neurodevelopment

Preserve maturation pathways.

Endothelium

Restore vascular integrity.

Microbiome

Restore gut intelligence.

Immune System

Re-establish self-tolerance.

Growth

Normalize growth trajectory.

SECTION 4.13

SEPSIS RECOVERY ENDPOINTS

Clinical

Hemodynamic stability

No respiratory escalation

Improved feeding tolerance

Laboratory

Lactate normalization

CRP decline

Procalcitonin decline

Neuroimmune

Stable STRI

Stable ANMS

Reduced inflammatory burden

Growth

Weight gain trajectory restored

PAGE 4 COMPLETION

Next Page (Page 5):

Necrotizing Enterocolitis (NEC) SOP

Microbiome Stabilization Protocol (Full Deployment)

Gut Intelligence Surveillance System

Intestinal Ischemia Prevention Program

Surgical NEC Workflow

RHENOVA Gut-Endothelium Axis Protection Program

Feeding Advancement & Recovery Intelligence Protocol

MASTER REGISTRY INDEX

SCF-DBI-NICU-SEPSIS-0001 — Neonatal Sepsis SOP

SCF-DBI-NICU-EOS-0001 — Early-Onset Sepsis Workflow

SCF-DBI-NICU-LOS-0001 — Late-Onset Sepsis Workflow

SCF-DBI-NICU-NI-0001 — Neuroimmune Intelligence Monitoring Program

SCF-NICU-GPB-SEPSIS-0001 — Glycocalyx Protection Bundle for Sepsis

SCF-RHENOVA-STRI-NICU-0001 — Neonatal Self-Tolerance Preservation Program

SCF-ANMS-SEPSIS-0001 — Neonatal Sepsis Escalation Framework

SCF-DBI-NICU-MSP-0001 — Microbiome Stabilization During Sepsis Program

SCF-DBI-PCR-SEPSIS-0001 — Preventative-Curative-Restorative Neonatal Sepsis Architecture

SCF-RHENOVA-NICU-SEPSIS-0001 — Project RHENOVA Neonatal Sepsis Intelligence Platform